Invasive Waveform Diagnostics — Arterial & Right Heart

Waveform Anatomy & Physiology

The arterial pressure waveform is a beat-by-beat integration of cardiac function, vascular resistance, and volume status. Each labeled inflection point reflects a discrete physiologic event. Hernandez et al. (2022) emphasize that clinicians who reduce the waveform to mean arterial pressure (MAP) alone are discarding a continuous, information-dense hemodynamic signal.

Annotated Radial Arterial Waveform — Single Beat

Anacrotic Limb systole

Sharp upstroke from diastolic nadir to systolic peak. Slope reflects LV contractility (dP/dt) and aortic compliance. Steep = vigorous LV. Gradual = poor contractility or aortic stenosis (slow-rising "pulsus parvus et tardus").

Systolic Peak (SBP) systole

Maximum transmitted force from LV ejection into the aorta. Increases with higher stroke volume, faster heart rate, and reduced aortic compliance (stiff vessels → higher SBP). Site-dependent: radial SBP often exceeds aortic SBP by 10–20 mmHg.

Dicrotic Notch (Incisura) transition

Transient pressure deflection marking aortic valve closure. Position reveals SVR: proximal (high on downstroke) = high SVR/vasoconstiction. Low/absent = low SVR states (sepsis, vasodilation). Migrates distally with peripheral measurement (less distinct at radial vs. aortic root).

Dicrotic Wave

Small positive pressure wave immediately after the notch, generated by elastic recoil of the aortic wall (Windkessel effect). Accentuated with increased aortic compliance (young patients); blunted in atherosclerosis or hypovolemia.

Diastolic Run-off

Exponential decay from notch to the next systolic upstroke. Rate of decay reflects peripheral vascular resistance. Rapid run-off → low SVR (AR, AVM, sepsis, nitroprusside). Prolonged slow decay → high SVR or aortic stenosis.

Diastolic Nadir (DBP) end-diastole

Minimum pressure in the cycle. Maintained by SVR and heart rate (more cycles = less run-off time = higher DBP). Aortic regurgitation: DBP drops precipitously. Low DBP + low SVR: pharmacologic vasodilation or distributive shock.

Derived Hemodynamic Parameters

As Hernandez et al. (2022) state: "The richness of information embedded in each beat extends far beyond MAP." The following parameters are derivable at the bedside — each targets a distinct physiologic domain.

Key Formulas MAP = DBP + ⅓(SBP − DBP) // approximation; true MAP = ∫P(t)dt / cycle duration PP = SBP − DBP // pulse pressure; stroke volume surrogate PPV = (PP_max − PP_min) / [(PP_max + PP_min) / 2] × 100 // over respiratory cycle SPV = SBP_max − SBP_min // systolic pressure variation SVV = (SV_max − SV_min) / SV_mean × 100 // requires pulse contour analysis

Parameter	Normal Range	Physiologic Meaning	Clinical Trigger
MAP	70–105 mmHg	Mean perfusion pressure; organ flow determinant. Target ≥65 in sepsis, ≥80 in traumatic brain injury.	Critical <65 = shock perfusion threshold
Pulse Pressure (PP)	40 mmHg	Proportional to SV and inversely proportional to aortic compliance. PP >40% of SBP → high SV state or aortic stiffness.	Volume PP <25 suggests low SV or tamponade
PPV	<13%	Dynamic preload index. Mechanically ventilated patients only (tidal volume ≥8 mL/kg, sinus rhythm). Reflects heart–lung interaction.	Fluid resp. ≥13% predicts volume responsiveness
SPV	<10 mmHg	Older index; includes Δ-down component (preload loss) and Δ-up (Valsalva-like increase). Less specific than PPV.	Preload Δ-down >5 mmHg = preload-dependent
SVV	<10–13%	Beat-to-beat SV variation from pulse contour. Requires dedicated algorithm (LiDCO, PiCCO, EV1000, ClearSight).	Fluid resp. Same threshold and limitations as PPV
dP/dt (upstroke slope)	Qualitative	Proxy for LV contractility. Derived from rate-of-rise of the anacrotic limb. Decreased in cardiogenic shock, increased with inotropes.	Contractility Assess trend not absolute value

Heart–Lung Interaction: PPV & SPV

Scheeren and Saugel (2018) identify PPV and SPV as the mechanistic foundation for predicting intraoperative hypotension and guiding goal-directed fluid therapy. The physiology is rooted in the Frank-Starling relationship under cyclic pleural pressure swings.

PPV — Respiratory Cycle Variation (Mechanically Ventilated)

Mechanism — Inspiration

Positive-pressure inspiration increases intrathoracic pressure → compresses pulmonary vasculature → transiently augments LV preload (brief Starling augmentation) → increases SV and PP.

In a preload-dependent patient on the steep portion of the Starling curve, this swing is exaggerated — hence high PPV = fluid responsive.

Mechanism — Expiration

Expiration withdraws this augmentation. In a volume-depleted patient, the PP drops substantially. Preload-independent patients (already on the flat of the Starling curve) show minimal PPV even at low volumes.

Scheeren & Saugel (2018): PPV-guided GDT reduced intraoperative hypotension and vasopressor requirements in elective surgery.

PPV Validity Conditions — Non-Negotiable

Required: (1) Controlled mechanical ventilation. (2) Regular sinus rhythm. (3) Tidal volume ≥8 mL/kg (ideally; PPV unreliable at Vt <6 mL/kg — lung-protective ventilation era caveat). (4) Closed chest. (5) Absence of right heart failure.

Invalidity contexts: spontaneous breathing, atrial fibrillation, ARDS (low Vt), open chest, abdominal compartment syndrome, severe RV dysfunction, very high PEEP. Use alternatives (PLR, echocardiography, end-expiratory occlusion test) when PPV is invalid.

Pathologic Waveform Morphologies

Hernandez et al. (2022) specifically highlight that waveform shape provides immediate diagnostic information about cardiac and vascular pathology. The following patterns should be instantly recognizable.

Comparative Waveform Patterns — Pathophysiologic States

Pattern	Upstroke	PP	Notch	DBP	Differential
Normal	Sharp	~40 mmHg	Distinct, mid-dicrotic	60–80	—
Low SVR	Sharp / steep	↑↑ Wide	Low on limb or absent	↓↓	Sepsis, vasodilators, liver failure, AVM
High SVR	Brisk	↑ (stiff vessels)	High / prominent	↑	Vasoconstriction, cardiogenic shock (cold)
Pulsus parvus et tardus	Slow, delayed	↓ Narrow	Absent / merged	Normal	Aortic stenosis, cardiogenic shock
Water-hammer pulse	Very rapid, tall	↑↑↑ Very wide	Absent	↓↓↓	Aortic regurgitation, PDA, Paget's
Pulsus alternans	Alternating amplitude	Alternates	Variable	Variable	Severe LV failure, bigeminy
Pulsus paradoxus	Normal morphology	Normal	Normal	Normal	Cardiac tamponade, severe asthma, COPD
Pulsus bisferiens	Double-peaked systole	↑ Wide	Between peaks	↓	Combined AS+AR, HOCM

Predicting Fluid Responsiveness

The conceptual backbone from Scheeren and Saugel (2018): only ~50% of hemodynamically unstable patients respond to a fluid bolus. Static parameters (CVP, PAOP) are poor predictors. Dynamic indices derived from the arterial waveform are the current standard — but each has conditions of validity.

Frank-Starling Conceptual Anchor

A patient on the steep portion of the Starling curve (preload-dependent): small ↑ in preload → large ↑ in SV. PPV/SPV swing is exaggerated. Fluid will increase CO.

A patient on the flat portion (preload-independent): ↑ preload → minimal ↑ in SV. PPV/SPV swing is small. Fluid will not help and may cause harm (VILI, fluid overload, abdominal compartment syndrome).

Check PPV/SVV validity CMV + sinus rhythm + Vt ≥8 mL/kg + closed chest + no severe RV dysfunction. If invalid → proceed to alternative tests.

Read the PPV threshold — mind the gray zone PPV ≥13% predicts fluid responsiveness. But Cannesson et al. (Anesthesiology 2011, n=413) demonstrated a gray zone of 9–13% where prediction is inconclusive — roughly one-quarter of OR patients fall here. The French multicenter ICU pooled analysis (Biais et al. 2014, n=556) found an even wider gray zone (4–17%, 62% of patients) with PPV AUC only 0.73. Inside the gray zone, do not trust PPV alone — go functional.

Tidal volume challenge — rescue for the gray zone Transiently increase Vt from 8 to 12 mL/kg for 2 minutes and re-read PPV. An augmented PPV12 carries excellent discrimination (AUC 0.935; sensitivity 95%, specificity 72%). Useful precisely when baseline PPV at protective Vt is indeterminate.

Passive Leg Raise (PLR) test — when PPV invalid Autotransfusion of ~300 mL from lower extremities. The strongest functional test available: Monnet, Marik & Teboul (Intensive Care Med 2016, 21 studies, 991 patients) report pooled sensitivity 86%, specificity 92%, AUC 0.95 — independent of ventilation mode and cardiac rhythm. Best threshold: PLR-induced ↑CO ≥10±2%. Reversible, no fluid given, works in AF and spontaneous breathing.

PLR — five rules, not a drop of fluid (Monnet & Teboul) (1) Start from semi-recumbent, not supine. (2) Measure CO/SV directly — not pulse pressure (PP-based PLR sensitivity falls to ~56%). (3) Use a real-time method that catches transient change — the effect vanishes within ~1 min. (4) Avoid pain/cough/discomfort that triggers adrenergic response. (5) Beware intra-abdominal hypertension: IAP >15–20 mmHg causes false negatives — lower the threshold to ~5%.

End-Expiratory Occlusion Test (EEOT) 15-second end-expiratory pause → increases preload. ↑PP or ↑CO ≥5% = fluid responsive. Requires tolerance of apnea — not practical in all patients.

Mini-fluid challenge 100 mL crystalloid bolus over 1 minute with real-time SV monitoring. ↑SV ≥6–10% = fluid responsive. Limits exposure in patients where harm is likely (oliguria, pulmonary edema).

When PPV is Reliable

Controlled mechanical ventilation
Sinus rhythm (regular RR)
Vt ≥8 mL/kg IBW
No spontaneous respiratory effort
Closed chest (not open thoracotomy)
No severe RV failure
No severe arrhythmia

When PPV is Unreliable

Spontaneous or assisted breathing
Atrial fibrillation / irregular rhythm
Low Vt ventilation (<6–8 mL/kg) — ARDS
Open chest / thoracotomy
Acute cor pulmonale / severe RV failure
Abdominal hypertension (↑IAP >12)
Very high PEEP (>10 cmH₂O)

Intraoperative Hemodynamic Management

Scheeren and Saugel (2018) propose a prediction → prevention → personalization framework for intraoperative hypotension (IOH), defined as MAP <65 mmHg for ≥1 minute. IOH is associated with myocardial injury, AKI, and 30-day mortality even in brief episodes.

IOH — The 3P Framework (Scheeren & Saugel 2018)

Predict: Pre- and intraoperative risk stratification. PPV >13% before induction predicts post-induction hypotension. Continuous non-invasive arterial pressure (ClearSight, CNAP) enables pre-induction waveform data.

Prevent: Goal-directed fluid therapy (GDT) using PPV/SVV to optimize SV on the Starling curve before hypotension occurs. Vasopressors (norepinephrine, phenylephrine) titrated to MAP — initiated before hypotension, not in response to it.

Personalize: Target MAP to the individual. Autoregulation assessment (transcranial Doppler, cerebral oximetry) defines the optimal MAP for each patient — particularly relevant in neurosurgery, cardiac surgery, CKD, and chronic hypertension.

Hypotension Prediction Index (HPI) — The "Predict" Pillar, Operationalized

The natural extension of the Scheeren/Saugel prediction concept. HPI is a machine-learning algorithm that analyzes ~50 features of the arterial pressure waveform (slope, area, complexity, dynamic indices) and outputs a 0–100 score for impending hypotension. It alerts the clinician before MAP falls below 65, converting reactive treatment into pre-emptive intervention.

Performance: predicts hypotension 5 min in advance with sensitivity and specificity ~0.86; an HPI of 80–89 gives a median ~6 minutes of warning before MAP <65. Validated on both invasive arterial lines and non-invasive finger-cuff waveforms (ClearSight), extending applicability to nearly any surgical patient. In major abdominal surgery, HPI-guided care reduced the time-weighted average of hypotension versus standard pulse-contour monitoring.

Caveat: HPI is not magic — it inherits every waveform-quality dependency in Section 07 (damping, leveling, signal artifact). A poorly damped trace produces a poor HPI. It also draws controversy over how its training data defined events; treat the score as a prompt to look at the patient and the waveform, not a substitute for either.

Hemodynamic State	Waveform Clues	Primary Intervention	Pitfall
Hypovolemia (preload-dependent)	↑PPV, ↑SPV, small PP, narrow waveform, prominent respiratory variation	Fluid challenge (titrated). Check response within 2–3 min.	Over-resuscitation if already on Starling plateau
Vasodilation (low SVR)	Wide PP, rapid diastolic run-off, low DBP, low-positioned notch	Vasopressor (norepinephrine first-line). Assess DLCO: does MAP improve without ↑PP?	Fluid loading a vasodilated state causes volume overload
Cardiogenic (low SV)	Narrow PP, slow upstroke, high SVR, pulsus alternans in severe LV failure	Inotrope (dobutamine, milrinone). Reduce afterload cautiously.	Vasopressors alone worsen afterload, reduce CO further
Mixed (low SV + low SVR)	Low amplitude + wide PP + low DBP. Difficult to parse at bedside.	Echocardiography. Target SV optimization before vasopressor escalation.	Treating SVR alone while SV remains inadequate

Technical Setup, Troubleshooting & Artifacts

Garbage in, garbage out. Hernandez et al. (2022) note that the waveform is only as trustworthy as the system generating it. Transducer positioning, damping, and zeroing errors produce false alarms and misguided interventions.

Zeroing & Leveling

Transducer must be at the phlebostatic axis (4th ICS, mid-axillary line) for MAP accuracy. Each 10 cm below → +7.4 mmHg false elevation. Re-zero after every position change and every 8–12 hours. "Fast-flush" test to confirm optimal damping before relying on waveform dynamics.

Over-Damping

Air bubbles, clots, long compliant tubing, kinking. Result: falsely low SBP, falsely high DBP, MAP relatively preserved. Waveform appears "slurred" — rounded upstroke, absent notch. Fast-flush test: slow return to baseline, no oscillations.

Under-Damping (Resonance)

Stiff short tubing, high cardiac output, tachycardia. Result: falsely high SBP, falsely low DBP, oscillatory artifact. Fast-flush test: >2 oscillations before return to baseline. Correct with the Gardiner chamber or resonance-reducing devices.

Optimal Damping

Natural frequency >25 Hz with damping coefficient 0.6–0.7. Fast-flush test: 1–2 oscillations, crisp return to baseline. Stiff (non-compliant) short tubing, minimal stopcocks, no air. Standard tubing length ≤120 cm.

Site-Specific Amplification

Radial SBP typically 5–20 mmHg higher than aortic root SBP due to wave reflection. DBP and MAP closer. Femoral = closer to aortic. Post-cardiopulmonary bypass: radial-aortic gradient can exceed 30 mmHg ("radial artery vasospasm") — use femoral or resume aortic monitoring.

Post-CPB Radial Artifact

After cardiac surgery and rewarming, radial arterial pressure can significantly underestimate aortic pressure for 20–60 minutes. Mechanism: peripheral vasospasm and thermoregulatory vasoconstriction. Use femoral or aortic root for these patients until resolution confirmed.

Damping Spectrum — Fast Flush Test Interpretation

Pulse Contour Analysis & CO Estimation

Beyond qualitative waveform reading, pulse contour algorithms (PiCCO, LiDCO, EV1000/VolumeView, Edwards ClearSight) derive continuous beat-by-beat SV and CO from the arterial pressure waveform morphology — primarily the area under the systolic portion and the waveform's shape characteristics.

Pulse Contour Principle (Wesseling/Modelflow) SV_beat ≈ ∫[systolic area] / Zao(t) // Zao = aortic impedance (estimated from MAP, HR, demographics) CO = SV × HR SVV (%) = (SV_max − SV_min) / SV_mean × 100 // over 30-sec window or respiratory cycle

Clinical Limitation Note

Pulse contour algorithms require periodic calibration (thermodilution via central venous catheter for PiCCO/LiDCO) or uncalibrated population-based estimation (FloTrac/Vigileo, ClearSight). Accuracy deteriorates with irregular rhythms, severe vasomotor instability, and aortic regurgitation. Hernandez et al. (2022) caution that SV estimates should always be interpreted alongside waveform morphology — not replaced by them.

System	Calibration	Access Required	Key Output	Pearls / Limitations
PiCCO	Transpulmonary thermodilution	Central + femoral/axillary arterial	CO, SVV, ITBVI, ELWI	Provides pulmonary edema index (ELWI). Recalibrate with vasopressor changes.
LiDCO Plus	Lithium dilution	Peripheral IV + arterial	CO, PPV, SVV, SV	No central line needed. Cannot use in patients on lithium or early post-NMB.
FloTrac / EV1000	Uncalibrated (population algorithm)	Arterial line only	CO, SVV, SV	Convenient; accuracy limited in extreme SVR states. Recalibrates every 60 sec.
ClearSight (non-invasive)	Uncalibrated (vascular unloading)	Finger cuff	CO, SV, MAP, PPV	Enables pre-induction monitoring. Less accurate in poor peripheral perfusion/vasoconstriction.

Bedside Waveform Interpretation — Rapid Algorithm

→

Step 1: Is the system reliable? Transducer level correct? Fast-flush test: optimal damping? No kinks, bubbles, or long compliant tubing? If not → fix first.

→

Step 2: What is the MAP? <65 = action threshold. But MAP alone is insufficient — note the DBP and SBP that created it. High SBP + low DBP (wide PP) ≠ same as narrow PP hitting same MAP.

→

Step 3: What is the pulse pressure? Narrow PP (<25–30): low SV, tamponade, AS, hypovolemia. Wide PP (>60): aortic regurgitation, sepsis, high CO state, arterial stiffness.

→

Step 4: What does the upstroke tell you? Steep = good LV contractility. Slow/gradual = cardiogenic or AS. Bisferiens (double peak) = HOCM or combined AS+AR.

→

Step 5: Where is the dicrotic notch? High = high SVR (vasoconstriction). Low = low SVR (sepsis, nitroprusside). Absent radially ≠ absent centrally (normal peripheral dampening).

→

Step 6: Is there respiratory variation? Watch the monitor screen over 5–10 breaths. Visible swings ≥13% PPV in a CMV patient = preload-dependent. If patient is breathing spontaneously, use PLR test instead.

→

Step 7: Is there beat-to-beat variation? Alternating amplitude = pulsus alternans → severe LV failure or bigeminy. SBP drop >10 mmHg with inspiration = pulsus paradoxus → tamponade, severe obstructive disease.

→

Step 8: Integrate with clinical context Waveform → hemodynamic phenotype → targeted intervention (fluid, vasopressor, inotrope, drainage). Re-assess after each intervention. The waveform is a real-time loop — use it continuously, not as a one-time snapshot.

Part II Invasive Right Heart & PAC Waveform Diagnostics

PA Catheter Anatomy, Lumens & West Zones

The balloon-tipped flow-directed pulmonary artery catheter (Swan-Ganz) is a 7.5 Fr, 110 cm catheter with four functional ports. Each lumen provides both pressure data and infusion access at specific anatomic sites. Understanding the catheter anatomy is prerequisite to reading its waveforms reliably.

Distal Lumen tip — PA

At the catheter tip, in the pulmonary artery. Measures PA pressure, PCWP (when balloon inflated), and pulmonary arterial blood for SvO2 sampling. This is the waveform-rich port.

Proximal Lumen 30 cm from tip — RA

Opens in the right atrium (30 cm from tip in most adults). Measures CVP/RAP and provides the injectate port for thermodilution cardiac output. RA waveform is read here.

Balloon Port tip inflation

Inflates the 1.5 mL latex balloon at the tip for flotation during insertion and for PCWP measurement. Balloon must fully deflate after wedge — sustained wedge = PA infarction risk.

Thermistor 4 cm from tip

Temperature sensor 4 cm proximal to tip. Detects cold injectate bolus passing by for thermodilution CO calculation. CCO-capable catheters use a thermal filament for continuous output.

VIP / Infusion Lumen ~14–26 cm from tip

Mid-catheter port sitting in the RV or right-sided central venous circulation. Used for drug infusion, does not measure waveforms in most standard catheters.

Continuous SvO2 fiberoptic catheter

Specialized catheters include a fiberoptic oximetry channel for continuous mixed venous O₂ saturation. Critical in cardiogenic shock monitoring where SvO2 trends precede clinical deterioration.

WEST

West Lung Zones — Why Catheter Position Determines PCWP Accuracy

PCWP is only a valid surrogate for left atrial pressure when the catheter tip resides in West Zone 3 — where continuous blood flow guarantees a patent column between the distal catheter and the left atrium. The balloon, when inflated in Zone 3, stops flow locally and the pressure equilibrates upstream to the LAP.

West Zones — Lung Pressure Relationships & Flow

Flotation Sequence: RA → RV → PA → PCWP

As the catheter advances with the balloon inflated, the pressure waveform transitions through four characteristic patterns. Recognizing these transitions in real-time determines catheter position without fluoroscopy — and prevents life-threatening misplacements.

Pressure Waveform Progression During Catheter Flotation

Critical Transition Recognition

RA → RV: Sudden dramatic increase in systolic pressure (from ~5 to ~25 mmHg) with low diastolic remaining near baseline. Waveform becomes square-wave-like. No dicrotic notch.

RV → PA: Systolic pressure stays the same (~25 mmHg) but diastolic pressure jumps (from ~4 to ~10–12 mmHg). Dicrotic notch appears. This is the most important transition — confirms tip has crossed the pulmonic valve.

PA → PCWP: Overall pressure drops and waveform loses its PA pattern — returns to low-amplitude undulating pattern with visible a and v waves. If balloon inflation does not produce wedge waveform at appropriate catheter depth (45–55 cm from right IJ), do not advance further — PA rupture risk.

Position	Systolic (mmHg)	Diastolic (mmHg)	Mean (mmHg)	Distinguishing Feature
Right Atrium	—	—	2–6	a, c, v waves + x, y descents. No systolic spike.
Right Ventricle	15–30	2–8	—	High systolic, low diastolic. No dicrotic notch. Square-wave.
Pulmonary Artery	15–30	4–12 (14)	10–20	Diastolic jumps vs RV. Dicrotic notch. PA systolic = RV systolic (if no PS).
PCWP (wedge)	—	—	6–12	Pressure drops, a and v waves return, delayed vs RA. Approximate LAP.

Right Atrial Waveform: a, c, v Waves & x, y Descents

The RA pressure waveform is a low-amplitude, information-dense tracing. Each component maps to a specific mechanical event in the right heart. The JVP exam at the bedside reflects the same waveform, making RA catheter data a numerical ground-truth for the clinical exam.

RA Waveform — ECG Correlation & Component Anatomy

Component	Cardiac Event	ECG Timing	↑ Amplitude Suggests	↓ / Absent Suggests
a wave	RA contraction (atrial kick)	After P wave, before QRS	Tricuspid stenosis, RV hypertrophy, reduced RV compliance, complete heart block (cannon a)	Atrial fibrillation (absent a), atrial flutter
c wave	Tricuspid valve closure + bulging into RA	Just after QRS onset	Tricuspid regurgitation (merges with v)	Often not visible in peripheral lines; may be absent normally
x descent	Atrial relaxation + TV annular descent toward apex during systole	During ST segment	Prominent in tamponade (dominant x) and constrictive pericarditis	Attenuated in RV failure, elevated in constrictive (paradoxically prominent y too)
v wave	Passive atrial filling with TV closed (ventricular systole)	Near/after T wave	Tricuspid regurgitation (massive), ASD, RV failure. In PCWP: MR, VSD	Hypovolemia
y descent	Tricuspid valve opens → RA empties into RV	After T wave	Constrictive pericarditis (rapid, steep y = fast early filling)	Blunted/absent in cardiac tamponade (restricted diastolic filling)
Z point	End-diastole — measurement reference	At or just after QRS	PCWP and RAP should be measured at end-expiration at the Z point (onset of QRS), not at peak. Measuring at peak a wave overestimates filling pressure.

Pathologic RA Waveform Patterns

The RA waveform is one of the highest-yield diagnostic tracings in invasive hemodynamics. The morphology of the a and v waves and their relationship to the x and y descents form the basis of differentiating tamponade from constriction, identifying valvular pathology, and diagnosing arrhythmias at the bedside.

Comparative Pathologic RA Patterns — Six-Panel SVG

Finding	Cardiac Tamponade	Constrictive Pericarditis	Restrictive CMP
x descent	Prominent ↑↑	Prominent ↑↑	Variable
y descent	Blunted/Absent	Steep ↑↑	Prominent
Kussmaul sign (RAP↑ with insp.)	Absent	Present ✓	Absent
Pulsus paradoxus (>10 mmHg)	Present ✓	Usually absent	Absent
Square root sign (RV)	Absent	Present ✓	Present ✓
Pressure equalization	RA=RVd=PAd=PCWP (±5)	RA=RVd=PAd=PCWP (±5)	LVEDP − RVEDP >5
PA systolic	<50 mmHg	<50 mmHg	Often >50 mmHg
RVEDP / RVSP	<1/3	>1/3 ✓	<1/3
Ventricular interdependence	↑↑ Coupled (liquid)	↑ Uncoupled	Absent/minimal
Key differentiator	Effusion on echo; X dominates	Kussmaul + steep Y + √ sign	LVEDP-RVEDP >5; PASP >50; endomyocardial Bx

PCWP Pathology & Giant V Waves

The PCWP is a left-heart window delivered through the pulmonary vasculature. Its morphology reveals left atrial compliance, mitral valve function, and LV end-diastolic filling pressures. Giant V waves are one of the most recognizable and action-forcing waveform patterns in invasive hemodynamics.

PCWP Patterns — Normal, Giant V Wave (MR), Elevated (LHF), Mitral Stenosis

Giant V Wave — What It Actually Means

Classic definition: V peak − mean PCWP ≥10 mmHg → specificity 94% for severe MR, sensitivity only 27% (Karger, 2018, n=126 RHCs). The traditional high-bar definition is highly specific but misses most severe MR.

More sensitive: V − mean PCWP ≥7 mmHg (sens ~73%, spec ~64%). V waves also occur with any non-compliant left atrium (HFpEF, MS, post-AF cardioversion), VSD (shunt increases pulmonary venous return), and with MCS devices.

Practical rule: A giant V wave is proportionally dramatic. MR + dilated LA + elevated LVEDP → V waves >20 mmHg in virtually all patients. A V wave that exceeds the mean PCWP by <7 mmHg is rarely severe MR.

PCWP vs LVEDP — When They Diverge

PCWP overestimates LVEDP: Mitral regurgitation (giant V wave artificially elevates mean PCWP), non-compliant LA, Zone 1/2 position with PEEP (PCWP reflects Palv).

PCWP underestimates LVEDP: PEEP overcorrection, Zone 3 tip migration with patient movement, pulmonary venous obstruction (PVOD, pulmonary vein stenosis).

PCWP ≠ LAP: Mitral stenosis (LAP-LVEDP gradient, measure LAP directly via transseptal or LA pressure transducer). PEEP correction: true PCWP ≈ measured PCWP − (0.5 × PEEP [cmH₂O × 0.74 to convert]).

Derived Right Heart Parameters: SVR, PVR, CPO, PAPI, Fick, SvO₂

The PAC measures pressure and temperature directly. Everything else is derived. These calculations are the language of invasive hemodynamic management — understanding what they represent physiologically, not just their formulas, is what separates rote interpretation from real-time decision-making.

Core Derived Formulas // FLOW CO (thermodilution) = ∫ΔT(t)dt [Stewart-Hamilton] = avg of 3 injections (10mL cold saline) CO (Fick principle) = VO₂ / (CaO₂ − CvO₂) = VO₂ / (13.4 × Hgb × [SaO₂ − SvO₂]) CI = CO / BSA // normal 2.2–4.0 L/min/m² SV = CO / HR × 1000 // normal 60–100 mL/beat // RESISTANCE (Wood units = mmHg·min/L; × 80 = dyne·s·cm⁻⁵) SVR = (MAP − CVP) / CO × 80 // normal 800–1200 dyne·s·cm⁻⁵ PVR = (mPAP − PCWP) / CO × 80 // normal 20–120; <3 Wood units // PULMONARY GRADIENTS (pre- vs post-capillary PH distinction) TPG = mPAP − PCWP // transpulmonary gradient; normal <12 mmHg DPG = dPAP − PCWP // diastolic pressure gradient; normal <7 mmHg // TPG >12 or DPG ≥7 = pre-capillary (intrinsic PA disease) // TPG <12 and DPG <7 = isolated post-capillary PH (left heart) // ADVANCED HEMODYNAMICS CPO = MAP × CO / 451 // cardiac power output [Watts]; normal >0.6W; <0.6 = cardiogenic shock PAPI = (PASP − PADP) / RAP // PA pulsatility index; <0.9 = RV failure; <1.0 + CPO<0.6 = refractory shock // OXYGEN (SvO₂ and shunt) SvO₂ = SaO₂ − VO₂ / (13.4 × Hgb × CO) // normal 65–75% (PA blood) Qp/Qs = (SaO₂ − MvO₂) / (PvO₂ − PaO₂) // L-R shunt ratio; >1.5 = significant

Parameter	Normal	Critical Threshold	Physiology / Pearl
CO / CI	4–8 L/min / 2.2–4.0 L/min/m²	CI <2.2 = shock; <1.8 = cardiogenic shock	CI is CO normalized to body size — use BSA not weight. Low CI + high PCWP = cardiogenic. Low CI + low PCWP = hypovolemic or RV failure.
SVR	800–1200 dyne·s·cm⁻⁵ (10–15 Wood units)	<800 = vasodilatory; >1800 = severe vasoconstriction	SVR = afterload to LV. High SVR in cardiogenic shock increases MVO₂, worsens ischemia. Treat with vasodilators if CI acceptable. Low SVR in sepsis: vasopressors to target MAP ≥65.
PVR	<3 Wood units (240 dyne·s·cm⁻⁵)	>3 = pulmonary hypertension; >6 = severe	Pre-transplant evaluation threshold: PVR <3–5 for candidacy. Check reversibility with vasodilator challenge (nitric oxide or nitroprusside).
TPG	<12 mmHg	≥12 mmHg = pre-capillary component	Combined PH (both pre- and post-capillary) = mPAP >25 + PCWP >15 + PVR >3 + TPG >12. Distinguishes isolated post-capillary (elevated PCWP only) from mixed.
DPG	<7 mmHg	≥7 mmHg = pre-capillary component	Superior to TPG for diagnosing pre-capillary PH in LHD — less influenced by heart rate and cardiac output. dPAP − PCWP ≥7 = intrinsic PA disease even in the setting of elevated PCWP.
CPO	>1.0 W (resting)	<0.6 W = cardiogenic shock (strongest mortality predictor — SHOCK trial)	CPO = MAP × CO / 451. Integrates both pressure and flow in a single metric. CPO <0.6 + PAPI <1.0 = refractory cardiogenic shock — MCS threshold. Use MAP, not MAP-CVP, in most clinical reports.
PAPI	>1.85 (heart failure population)	<0.9 = RV failure; <1.0 + CPO <0.6 = worst prognosis	PAPI = (PASP−PADP)/RAP. Reflects RV stroke volume relative to RA filling pressure. Developed for RV infarct/RVAD weaning. Lim et al.: "PAPi is related to, but not a direct measure of, RV function."
SvO₂	65–75% (PA blood)	<60% = compensatory ↑extraction; <50% = critical; >80% = maldistribution or ↑CO	SvO₂ <65% with low CI = cardiogenic. SvO₂ >80% with ↓MAP = distributive (sepsis, cirrhosis). ScvO₂ (superior vena cava via CVC) typically 5–8% higher than true SvO₂. Trending SvO₂ is as important as its absolute value.
Fick CO	Requires measured VO₂	Assumed VO₂ = 125 mL/min/m² (Lafarge-Miettinen) introduces significant error	Gold standard for shunts and low CO states where thermodilution is unreliable (tricuspid regurgitation, irregular rhythms). True Fick requires metabolic cart (indirect calorimetry).

Thermodilution CO — Reliability Pitfalls

False high CO: Tricuspid regurgitation (injectate recirculates), intracardiac shunts, very cold room temperature, slow injection technique.

False low CO: Rapid injection during inspiration (maximally timed with respiratory cycle), catheter tip against PA wall (partial occlusion), warm injectate, prolonged injection time.

Protocol: 3 injections at random within the respiratory cycle, discard outliers >15% from the mean, average the remaining. In tricuspid regurgitation >moderate, use Fick CO — thermodilution is unreliable regardless of technique.

Hemodynamic Phenotyping: Shock & Complex Diagnoses

The RHC is the arbitrator of undifferentiated shock. When physical exam, echo, and clinical context are ambiguous, the full hemodynamic profile cuts through. The following table consolidates PAC findings across all major shock phenotypes — each column is a column you need to hold in working memory in the ICU and OR.

Parameter	Hypovolemic	Distributive (Sepsis)	Cardiogenic (LV)	RV Failure / PE	Tamponade	Constriction
CO / CI	↓	↑↑ (early); ↓ late	↓↓↓	↓	↓↓	↓
RAP / CVP	↓↓	↓ / N	↑	↑↑↑	↑ (equalized)	↑ (equalized)
PCWP	↓↓	↓ / N	↑↑↑	↓ / N	↑ (equalized)	↑ (equalized)
PASP	↓	↓ / N	↑↑	↑↑↑	N / ↑	N / ↑ (<50)
SVR	↑↑	↓↓↓	↑↑↑	↑↑	↑↑	↑
PVR	N	N / ↑ (ARDS)	↑ (reactive)	↑↑↑	N	N / ↑
SvO₂	↓	↑↑ (maldistrib.)	↓↓	↓	↓	↓
PAPI	N	N	↓ (RV stressed)	↓↓↓	↓	N / ↓
CPO	N / ↓	N / ↑	↓↓ (<0.6 W)	↓↓	↓↓	↓
RAP waveform	Small a/v	Normal/small	↑ a wave	↑↑ a, giant V (TR)	X>Y	M/W, steep Y, Kussmaul
PCWP waveform	Small	Normal	↑ flat or giant V (MR)	Low, normal morphology	Equalized, X>Y	Equalized, prominent Y
First-line Rx	Fluid	Vasopressor + fluid	Inotrope + afterload	Vasopressor + RV unload	Pericardiocentesis	Pericardiectomy

Intracardiac Shunt Detection — Oximetry Step-Up

Blood samples drawn during catheter withdrawal from PA → RV → RA → SVC/IVC detect left-to-right shunts via a "step-up" in oxygen saturation.

Significant step-up thresholds: SVC→RA: >7% (ASD). RA→RV: >5% (VSD). RV→PA: >5% (PDA or coronary AV fistula). A step-up at the ventricular level is the diagnostic hallmark of acute VSD post-MI — a life-threatening emergency.

Shunt ratio: Qp/Qs = (SaO₂ − MvO₂) / (PvO₂ − PaO₂). >1.5 = hemodynamically significant. >2.0 = surgical or transcatheter closure generally indicated. MvO₂ = mixed venous O₂ sat (PA sample). PvO₂ = pulmonary venous O₂ sat (assumed = SaO₂ in absence of shunt).

Pulmonary Hypertension Classification via RHC

Pre-capillary PH (Group 1, 3, 4, 5): mPAP >20 mmHg + PCWP ≤15 mmHg + PVR ≥3 Wood units. TPG >12, DPG ≥7. Treat the PA (prostacyclins, ERA, PDE5i).

Post-capillary PH (Group 2 — LHD): mPAP >20 mmHg + PCWP >15 mmHg + PVR <3 Wood units. TPG <12, DPG <7. Treat the left heart. PA vasodilators are contraindicated (can precipitate pulmonary edema).

Combined pre- and post-capillary PH (CpcPH): PCWP >15 + PVR ≥3 (or DPG ≥7). The PA has remodeled on top of chronic LHD. Reversibility testing with nitric oxide determines surgical risk in transplant/LVAD candidates.

Part III CVP · IABP · Drug Effects · LVAD/MCS · LV Waveform

Central Venous Pressure (CVP) — Dedicated Reference

CVP measured via a central venous catheter (CVC) produces the identical a/c/v/x/y waveform as the RA tracing in Section 12. What is absent from that section is the clinical context of CVC-based monitoring: its profound limitations as a fluid predictor, site-specific nuances, the JVP correlation, and the differential diagnosis of elevated CVP.

CVP as Fluid Responsiveness Predictor — The Evidence

Marik PE et al. (Crit Care Med 2008, 24 studies, 803 patients): CVP AUC 0.56 for predicting fluid responsiveness — statistically indistinguishable from a coin flip. Neither the absolute value nor its change after a bolus reliably predicts CO response.

Practical rule: CVP <2 mmHg = likely hypovolemic. CVP >15 = likely volume-overloaded or RV failure. Between those extremes, use dynamic indices (PPV, PLR, EEOT). Never use a single CVP value as a fluid trigger.

Normal Values & Site Differences

IJ / subclavian: 0–8 mmHg (mean ~4–5). Approximates RAP when no SVC obstruction exists.

Femoral CVP: 2–4 mmHg higher than IJ due to hydrostatic column and intra-abdominal pressure. Not interchangeable with RAP without correction — particularly important in obese patients and those with elevated IAP.

Kussmaul's sign: CVP rises with spontaneous inspiration (normal = falls 1–3 mmHg). Positive Kussmaul = constrictive pericarditis, RV failure, or rarely cardiac tamponade with loculated effusion.

JVP

JVP — Bedside Correlate of the CVP Waveform

The jugular venous pulse is the non-invasive surface expression of the same RAP waveform. Every component of the CVP tracing has a JVP equivalent visible at 30–45° head elevation. Mastery of one transfers directly to the other.

JVP/CVP Component Map & Clinical Correlations

Elevated CVP Cause	Waveform Clue	Key Distinguisher
RV failure	↑ v wave, steep y, elevated mean	↑ PA pressures, ↓ PAPI, ↓ CI, echo RV dilation
Cardiac tamponade	Prominent X, absent/blunted Y	Echo effusion, pulsus paradoxus, equalization of pressures
Constrictive pericarditis	M/W pattern, steep X AND Y	Kussmaul positive, RVEDP/RVSP >1/3, calcified pericardium
Tension pneumothorax	CVP ↑ acutely + absent breath sounds	Tracheal deviation, absent unilateral BS, hypotension — needle decompression first
High PEEP / air trapping	CVP tracks mean airway pressure	Reduce PEEP trial: CVP drops proportionally; PCWP less affected
SVC obstruction	↑↑ CVP via IJ, normal femoral	Arm/facial edema, collateral vessels, CT confirms
Tricuspid regurgitation	Giant CV wave, steep Y, no distinct a-x	Echo confirms; systolic hepatic vein flow reversal
Hypervolemia / overresuscitation	Proportionally elevated all components	Clinical context; all chambers dilated; PCWP also elevated

Intra-Aortic Balloon Pump (IABP) Waveform Analysis

The IABP operates on counter-pulsation: balloon inflation in diastole augments coronary perfusion; deflation just before systole reduces LV afterload. Reading the arterial waveform during IABP support requires distinguishing unassisted beats from assisted beats and recognizing four timing errors — each with a distinct waveform fingerprint that can be read at the bedside.

IABP Hemodynamic Targets Augmented Diastolic Pressure (DAP) ≥ Unassisted Systolic Pressure (uSBP) Assisted End-Diastolic Pressure (AEDP) < Unassisted End-Diastolic Pressure (uEDP) Assisted Systolic Pressure (aSBP) < Unassisted Systolic Pressure (uSBP) // reduced LV work

Normal IABP Timing (1:2) and Four Timing Error Patterns

Trigger Modes

ECG trigger (primary): Inflates on T-wave downslope, deflates before R wave. Most accurate in regular sinus rhythm. Artifact-sensitive. Pressure trigger (backup): Uses arterial pressure upstroke — useful in paced rhythms, arrhythmia. Internal/asynchronous: Fixed rate for CPR or severely arrhythmic patients where no reliable trigger is available.

Vasopressor & Inotrope Effects on Arterial Waveform Morphology

Every vasoactive agent leaves a morphologic fingerprint on the arterial trace. Understanding these patterns allows real-time confirmation of drug effect — detecting loss of response and identifying unintended hemodynamic consequences before they manifest clinically.

Waveform Signature by Drug Class — SVR vs Contractility Effects

Drug	Mechanism	PP	HR	Notch	Upstroke	Waveform Signature
Norepinephrine	α1 > β1	↓ Narrow	N / ↓ (reflex)	↑ High	Normal–brisk	↑DBP, ↑MAP, high notch, slower diastolic run-off — high SVR pattern
Vasopressin	V1R vasoconstriction	↓ Narrow	↓ (reflex vagal)	↑ High	Normal	Similar to NE. Synergistic with NE — allows lower NE dose. Less tachycardia.
Phenylephrine	Pure α1	↓ Narrow	↓↓ (reflex)	↑ High	Normal	Slower HR visible as wider beat spacing. Can ↓CO in LV dysfunction or hypovolemia.
Epinephrine	α + β1 + β2	↑ Wide	↑↑	Variable	↑↑ Steep	Fast upstroke, ↑SBP, ↑HR, ↑PP. At low dose: β-dominant (↓SVR, wide PP). At high dose: α-dominant.
Dobutamine	β1 > β2	↑↑ Wide	↑↑	↓ Low	↑↑ Very steep	Steep upstroke, wide PP, faster HR, low notch, rapid diastolic run-off — low SVR / high CO pattern.
Milrinone	PDE3i	↑↑ Wide	↑ Modest	↓↓ Very low	↑ Steep	Wide PP, very low notch, rapid run-off. ↓SVR + ↓PVR + ↑CO. Similar to dobutamine but less tachycardia, also unloads RV.
Nitroprusside	NO donor (↓SVR)	↑↑↑ Very wide	↑ (reflex)	↓↓↓ Near absent	Normal	Extremely rapid diastolic run-off, very low DBP. Tachyphylaxis develops. Cyanide toxicity at high doses.
NE + Dobutamine	Combined α/β	Moderate ↑	Modest ↑	Intermediate	↑ Steep	Mixed phenotype: ↑SBP + moderate PP widening. Standard combination in cardiogenic shock (↑CO + ↑SVR).
Levosimendan	Ca²⁺ sensitizer + K⁺ channel	↑ Wide	↑ Modest	↓ Low	↑ Steep	Sustained inotropic effect (metabolites active 7–9 days). Arterial waveform similar to dobutamine but longer-lasting effect after single infusion. Vasodilatory.

LVAD & Mechanical Circulatory Support Waveforms

Continuous-flow LVADs and modern MCS devices fundamentally alter the arterial waveform. The standard SBP/DBP paradigm fails — in fully supported patients, MAP is the only reliable pressure metric, and residual pulsatility becomes a real-time marker of native cardiac recovery.

MCS Arterial Waveform Signatures — Four-Panel Comparison

Device	Waveform Character	MAP Target	Key Monitoring Points	Danger Signs
LVAD (HM3)	Near-flat; artificial 2/min speed modulation creates ~15–20 mmHg artificial PP	70–80 mmHg	MAP only (SBP/DBP meaningless). Doppler for korotkoff sounds. Pulse ox may be absent.	PP suddenly >30 = AR developing through native aortic valve
Impella CP/5.5	Pulsatile waveform (native LV ejecting) + motor artifact spikes superimposed	≥65 mmHg	Proper positioning confirmed by waveform overlap of native + motor signal	Suction alarm = ventricular collapse → reduce speed immediately
VA-ECMO	Flat at full support → progressively pulsatile as LV recovers	65–85 mmHg	LV venting required if PCWP rises and LV distends without ejection. Pulsatility index = LV function surrogate.	Loss of pulsatility on weaning = LV failure. Elevated PCWP + flat trace = LV distension — add Impella or IABP for venting.
IABP	Augmented diastolic peak visible (see Section 18)	MAP via diastole augmentation	DAP > uSBP; AEDP < uEDP; aSBP < uSBP	Late deflation: AEDP > baseline EDP — retrigger or remove

LVAD Ramp Study

Titrates speed (RPM) from low to high while measuring MAP, PCWP, CO, and echo parameters. Goal: maximize unloading without suction events or septal shift rightward. Optimal speed = PCWP 10–15 + CI >2.2 + no septal shift. At each speed step, residual PP decreases — complete loss at any speed = suction threshold, reduce immediately. HM3 artificial pulse modulation (speed oscillation 2/min) maintains some PP even at full support.

LV Pressure Waveform & Aortic Pullback

Left heart catheterization provides direct LV pressure measurement — the highest-fidelity assessment of LV systolic and diastolic function available. Catheter pullback from LV to aorta quantifies outflow obstruction and is the gold standard for aortic stenosis severity and dynamic LVOT obstruction diagnosis.

LV vs Aortic Simultaneous Tracings — Normal, AS Gradient, HOCM Spike-and-Dome

LVEDP — Clinical Thresholds

Normal: 4–12 mmHg. Elevation reflects reduced LV compliance (hypertrophy, ischemia, diastolic dysfunction) or volume overload. Measured at the Z point (onset of QRS) on the LV pressure trace — not at the a-wave peak.

LVEDP >25 mmHg: pulmonary edema threshold acutely. Chronic LHF: ≥18 mmHg = elevated filling. Acute severe AR: LVEDP may equilibrate with aortic diastolic — pathognomonic of extreme severity (premature mitral valve closure on echo confirms).

Brockenbrough-Braunwald-Morrow (BBM) Sign

After a PVC, the compensatory pause allows greater LV filling. In fixed AS: larger next-beat SV → ↑aortic pulse pressure. In HOCM: larger next-beat contractility → worsened LVOT obstruction → aortic pulse pressure unchanged or decreases. This paradoxical response is pathognomonic for dynamic obstruction and distinguishes HOCM from fixed AS at catheterization.

Condition	LV Systolic	LVEDP	Aortic Systolic	Gradient	Distinguishing Feature
Normal	100–140 mmHg	4–12 mmHg	100–140 mmHg	None	LV = Ao systolic; no pullback step-up
Severe fixed AS	>180 mmHg	↑↑ 15–25+	80–100 mmHg	Mean >40; peak-peak >50	Slow aortic upstroke; pulsus parvus et tardus; BBM negative
HOCM (dynamic)	↑↑ variable	N to ↑	Spike-and-dome	Variable; worsened with provocation	Valsalva/amyl nitrite ↑gradient; BBM positive; gradient in LVOT not at valve
Severe AR	N to ↑	↑↑ (acute ≥25)	Wide PP (↑SBP/↓DBP)	None (no stenosis)	Water-hammer pulse; LVEDP→aortic DBP equalization in acute severe AR
Subaortic membrane	↑	N to ↑	N to ↓	Fixed, subvalvular level	Gradient disappears above membrane; AR common (jet lesion)

Part IV Specialized Populations & Clinical Contexts

Pregnancy Hemodynamics & Obstetric Emergencies

Pregnancy produces the most profound physiologic cardiovascular changes of any non-pathologic state. Applying non-pregnant normal values to a laboring patient generates false alarms and incorrect interventions. Invasive monitoring thresholds and waveform interpretation must be adjusted throughout gestation.

Parameter	Non-Pregnant	Term Pregnancy	Change	Mechanism
CO	4–5 L/min	6–7 L/min	↑ 40–50%	↑SV (plasma volume) + ↑HR 10–15 bpm
SVR	1200 dyne·s·cm⁻⁵	~900	↓ 20–30%	Progesterone vasodilation + placental low-resistance circuit
MAP / DBP	93 / 80 mmHg	85 / 68 (2nd trimester nadir)	↓ early, normalizes 3rd trimester	SVR drop outpaces CO rise in early pregnancy
Blood volume	~5 L	~7.5 L	↑ 45%	Plasma vol ↑50% > RBC mass ↑30% → physiologic dilutional anemia
PCWP	6–12 mmHg	6–10 mmHg	Unchanged or slightly ↓	↑CO offsets filling pressure rise
CVP	0–8 mmHg	0–6 mmHg	↓ or unchanged	↓SVR, ↑venous compliance
PVR	100–200 dyne·s·cm⁻⁵	60–120	↓ 30%	Progesterone-mediated pulmonary vasodilation
Peak CO post-delivery	—	+20–30% above term peak	Immediate postpartum	Autotransfusion from uterine contraction (~500 mL mobilized)

Aortocaval Compression — Supine Hypotension Syndrome

After ~20 weeks, the gravid uterus compresses the IVC in the supine position, reducing venous return and CO by up to 30%. Classic: maternal hypotension + fetal distress when supine. Intervention: 15° left lateral tilt — mandatory for any pregnant patient >20 weeks in respiratory or cardiac arrest. Manual uterine displacement if full tilt impractical. Failure to maintain tilt during resuscitation is a common fatal error.

Obstetric Hemorrhage

Modified shock index (HR/SBP) >0.9 = significant hemorrhage in pregnancy. Arterial waveform: ↑HR, narrowing PP (early compensation), then ↓MAP + ↑PPV (late). Target MAP ≥65; permissive hypotension until surgical hemorrhage control. Massive transfusion: 1:1:1 (pRBC:FFP:Plt). TXA 1g IV within 3 hours of onset. Uterotonic cascade: oxytocin → methylergonovine → carboprost → misoprostol.

Amniotic Fluid Embolism (AFE)

Sudden massive ↑PVR → RV failure → distributive-obstructive shock + DIC. Arterial waveform: initially narrow PP (↓CO), then wide PP as vasodilation ensues. PAC shows ↑↑PAP → RV failure → ↓PCWP + ↓CO. Indistinguishable from massive PE hemodynamically — echo differentiates. Treatment: supportive (vasopressors, MCS), correct DIC aggressively.

Preeclampsia / Eclampsia

Hemodynamic paradox: ↓CO + ↑↑SVR (opposite of normal pregnancy physiology). Waveform: ↑MAP, narrow PP, high notch, ↑DBP. PAC (rarely needed): normal/low PCWP despite edema — vasoconstriction-mediated distribution. Treat: labetalol/hydralazine/nifedipine for BP, MgSO₄ for seizure prophylaxis, delivery for definitive management.

Peripartum Cardiomyopathy

Last month of pregnancy to 5 months postpartum. De novo LV dysfunction (EF <45%). Hemodynamic profile: ↓CO, ↑PCWP, ↑SVR — cardiogenic shock pattern. Waveform: narrow PP, slow upstroke, pulsus alternans in severe cases. Recovery in ~50% by 6 months. Bromocriptine (prolactin inhibitor) may improve outcomes (European evidence).

Septic Shock Hemodynamic Evolution

Septic shock progresses through distinct hemodynamic phases with dramatically different waveform and PAC profiles at each stage. Treating late cold shock with the same approach as early warm shock — or vice versa — is a common and lethal error.

Phase	Arterial Waveform	CO/CI	SVR	PCWP	SvO₂	Priority Intervention
Early / Warm Compensated hyperdynamic	Wide PP, low notch, rapid run-off, low DBP, ↑HR	↑↑ (hyperdynamic)	↓↓↓	↓ / N	↑ (maldistribution — mitochondrial dysfunction prevents O₂ extraction)	Vasopressors (NE first-line), fluid if PPV/PLR responsive, source control, abx within 1h
Mid / Transitional	PP normalizing with NE. PPV useful if valid CMV criteria met.	↑ or N	↓ requiring escalating NE	N or ↑ (fluids given)	Normalizing toward 65–75%	Optimize MAP, reassess fluid responsiveness, add vasopressin if NE >0.25 mcg/kg/min
Late / Cold Septic cardiomyopathy	Narrow PP (↓CO), slow upstroke, possible pulsus alternans if biventricular failure	↓↓ (myocardial depression)	Variable — mixed ↓SVR + ↓CO	↑↑	↓↓ <60%	Inotrope (dobutamine 2–20 mcg/kg/min); reassess source; consider RRT; levosimendan if available

Sepsis-Induced Cardiomyopathy

Occurs in 10–40% of septic shock patients. Reversible biventricular dysfunction driven by cytokine-mediated depression (TNF-α, IL-1β, nitric oxide). Echo: global hypokinesis, ↓EF, dilated RV and LV. Recovers in 7–10 days if patient survives. Dobutamine or low-dose epinephrine for hemodynamic support. Levosimendan has evidence in European and ESICM guidelines.

SvO₂ Paradox in Sepsis

Early septic shock: SvO₂ may be paradoxically high (75–85%) despite shock state — cytokine-mediated mitochondrial dysfunction prevents O₂ extraction even with adequate delivery (cytopathic hypoxia). This is why ScvO₂ >70% does not equal adequate resuscitation in sepsis. Track lactate clearance (>10% per 2h) and sequential organ failure as parallel endpoints alongside SvO₂.

Pediatric & Neonatal Hemodynamics

Pediatric hemodynamics are not scaled-down adults. Normal values shift dramatically with age, transitional neonatal circulation creates unique pathophysiology, and congenital lesions alter every pressure relationship assumed in adult monitoring.

Age Group	HR (bpm)	SBP (mmHg)	DBP (mmHg)	MAP (mmHg)	Minimum SBP formula
Neonate (0–28d)	100–160	60–90	30–60	45–65	≥60 (term)
Infant (1–12 mo)	80–140	80–100	50–70	60–80	≥70
Toddler (1–3 yr)	80–130	90–105	55–70	67–82	≥70 + 2×age(yr)
School age (6–12 yr)	70–110	100–115	60–75	73–88	≥70 + 2×age(yr)
Adolescent (12–18 yr)	60–100	110–130	65–80	80–97	Approaching adult values

Transitional Neonatal Circulation

Foramen ovale: Closes functionally at birth when ↑pulmonary venous return raises LA pressure above RA. Anatomic closure takes weeks. PFO persists in ~25% of adults.

Ductus arteriosus: Functional closure 12–24h (↑PaO₂ + ↓prostaglandins). Anatomic closure 2–3 weeks. PGE1 (alprostadil) maintains patency — life-saving in duct-dependent lesions (coarctation, pulmonary atresia, HLHS) until surgical repair. Start PGE1 before imaging if duct-dependent lesion suspected.

PVR: High in utero (collapsed lungs), drops dramatically at first breath. Failure = PPHN → R→L shunting through PFO/PDA → cyanosis refractory to supplemental O₂. Treatment: optimize ventilation, avoid hypoxia/acidosis, iNO, ECMO if refractory.

PPHN neonatal emergency

Persistent pulmonary hypertension of the newborn. Pre-ductal (right hand) SaO₂ > post-ductal (foot) by >10% = PDA R→L shunting. Suspect in any newborn with refractory hypoxemia. iNO 20 ppm is first-line. ECMO for refractory cases. Echo essential — no PAC in neonates.

Duct-Dependent Lesions

Systemic duct-dependent (coarctation, IAA, HLHS): closing ductus = cardiovascular collapse. Signs: differential upper/lower extremity pulses + saturations. Femoral pulse absent or weak. PGE1 immediately. Pulmonary duct-dependent (pulmonary atresia, critical PS): PGE1 maintains pulmonary blood flow. Differential sat reversed (post > pre in TGA with D-TGA pattern).

Pediatric Shock Recognition

Children compensate aggressively — BP maintained until 30–40% blood loss (compensated shock). HR rise + prolonged cap refill (>2s) + altered mental status = shock regardless of BP. "Hypotensive pediatric shock" = late and critical. Fluid resuscitation: 10–20 mL/kg crystalloid boluses (reassess after each). Intraosseous access if no IV within 60–90 sec.

CHD Hemodynamic Formulas

Qp/Qs >1.5 = hemodynamically significant L→R shunt. Coarctation: systolic gradient >20 mmHg upper-to-lower extremity (measure all 4 limbs). Fontan circuit (single ventricle palliation): passive hepatic venous return to PA — no pump. "Fontan failure" = ↑CVP + ↓CO without PCWP elevation. Fenestration allows R→L shunt as relief valve.

Pulmonary Embolism — Hemodynamic Profiles & Waveform Changes

Massive PE produces one of the most dramatic hemodynamic transformations visible on invasive monitoring: acute ↑↑PVR → RV pressure overload → septal leftward shift → LV underfilling → obstructive shock. The PAC profile is pathognomonic and guides tPA vs CDT vs ECMO decisions.

Parameter	Submassive PE (RV strain only)	Massive PE (hemodynamic collapse)	Post-Thrombolysis
MAP	≥90 mmHg (preserved)	<90 or drop >40 from baseline	↑ (SVR recovers)
PASP	35–50 mmHg (↑)	50–70 mmHg (↑↑)	↓ 30–50% within hours
RAP / CVP	↑ (>10 mmHg)	↑↑ (>15 mmHg)	↓
PCWP	N to ↓	↓ (LV underfilled)	↑ (LV filling resumes)
CO / CI	N to ↓	↓↓	↑
PAPI	↓ (1.0–1.8)	↓↓ (<0.9)	↑ (RV recovers)
SvO₂	↓ (55–65%)	↓↓ (<55%)	↑
RA waveform	↑ a wave, ↑ mean RAP	↑↑ a wave, TR pattern (giant CV) if acute RV dilation with annular failure	Normalizing

Intervention Thresholds

Systemic thrombolysis (tPA 100 mg/2h): Massive PE only (hemodynamic instability + imaging). Reduces PASP 30–50% within 2h. Contraindicated: recent surgery/stroke, active bleeding.

Catheter-directed thrombolysis (EKOS/CDT): Submassive PE with RV dysfunction (PAPI <1.85, RV:LV >0.9, troponin positive). Reduced dose tPA (10–24 mg over 12–24h), lower hemorrhagic risk.

VA-ECMO bridge: Refractory massive PE in pre-arrest or arrest. Supports systemic circulation while allowing concurrent catheter-directed therapy or surgical embolectomy. Provides time for RV recovery as clot lyses.

Paradoxical Embolism — PFO Physiology

Massive PE → ↑↑RAP → RAP exceeds LAP → PFO opens (present in ~25% of adults) → thrombus passes directly into systemic circulation → concurrent stroke + PE. Suspect when PE + stroke or limb ischemia occur simultaneously. Bubble echo confirms PFO. Prefer ECMO or surgical embolectomy over systemic thrombolysis to avoid propagating embolism through PFO.

Post-Cardiac Surgery Hemodynamic Monitoring

The post-CPB patient inhabits a unique hemodynamic state driven by systemic inflammatory response to bypass, myocardial stunning, temperature dysregulation, protamine reactions, and acute correction of the surgical lesion. Standard waveform assumptions require significant adjustment in this population.

Radial-Aortic Gradient Post-CPB

Radial SBP underestimates aortic SBP by 10–30 mmHg for 20–60 min post-bypass. Mechanism: peripheral vasospasm + cold cardioplegia rewarming. Clinical consequence: treating a "low" radial MAP that is actually adequate at the aortic root. Resolution: spontaneous within ~60 min or with vasodilator. Use femoral or aortic root pressure (via aortic cannula) if radial is grossly discordant.

Myocardial Stunning Post-Bypass

Transient LV dysfunction from ischemia-reperfusion injury after aortic cross-clamp. Duration: minutes to 6 hours. Waveform: slow upstroke, reduced PP, pulsus alternans in severe cases, low dP/dt. Treatment: temporary inotropic support (dobutamine, milrinone), AV sequential pacing (HR 80–90 optimizes CO), IABP if refractory.

Protamine Reaction

(1) Systemic hypotension only: MAP drops, SVR falls, wide PP — most common. (2) Pulmonary vasoconstriction: ↑↑PAP, ↑PVR, ↑RAP, RV strain — true protamine pulmonary vasoconstriction. (3) Anaphylaxis: distributive shock + bronchospasm + urticaria. Risk factors: fish allergy, prior protamine exposure, NPH insulin users. Treatment: epinephrine, calcium, slow/stop protamine infusion.

Post-Sternotomy Tamponade

Often loculated — may not equalize all chamber pressures. Presents as unexplained ↓CO + ↑CVP + ↓UO rather than classic equalization. CVP waveform: X>Y pattern, pulsus paradoxus may be absent with loculated clot. Do not attempt pericardiocentesis — surgical re-exploration required. Urgent bedside echo identifies culprit chamber compression.

Vasoplegia Post-CPB

Refractory vasodilation from complement activation, cytokines, contact pathway stimulation. Wide PP, low SVR, low DBP, ↑CO — distributive pattern despite adequate filling. Vasopressin 0.03–0.1 units/min is first-line (unaffected by CPB-inflammatory mediators). Methylene blue 1–2 mg/kg for refractory vasoplegia (NO synthase inhibition). Hydroxocobalamin as alternative.

NIRS Cerebral Oximetry

Regional cerebral O₂ saturation (rSO₂) via bifrontal NIRS. Normal 55–75%. Drop >20% from baseline or absolute <50% for >2–3 min correlates with neurocognitive injury. Integrates with arterial MAP: MAP drops + rSO₂ drops = hemodynamic cause (raise MAP). MAP stable + rSO₂ drops = O₂ delivery problem (Hgb, SaO₂, EtCO₂). CPB flow adjustments guided by rSO₂ reduce stroke and ICU LOS.

Part V Neuromonitoring

Intracranial Pressure Monitoring

ICP monitoring integrates directly with the arterial line: CPP = MAP − ICP. Every arterial beat drives a corresponding intracranial pressure pulsation. The relationship between MAP and ICP — measured continuously — defines cerebral autoregulatory status and allows individualized neuroprotective targets that no other monitor provides.

Core ICP Formulas CPP = MAP − ICP // target ≥60–70 mmHg in TBI; ≥70 during vasospasm window in SAH CBF = CPP / CVR // cerebral blood flow; maintained constant at CPP 50–150 in normal autoregulation PRx = correlation(MAP, ICP) [5-min rolling window] // pressure reactivity index PRx <0.2 = intact autoregulation · PRx >0.2 = impaired (pressure-passive) Optimal CPP = CPP value at minimum PRx on PRx–CPP curve // individualized target; typically 60–80 mmHg TBI ΔPaCO₂ → ~4% ΔCBF per 1 mmHg // hyperventilation: ↓PaCO₂ → vasoconstriction → ↓CBV → ↓ICP (temporary)

ICP Waveform — Normal P1/P2/P3 Morphology, Compliance Loss & Lundberg Waves

EVD gold standard

Catheter in lateral ventricle. Simultaneously measures ICP and drains CSF therapeutically. Gold standard accuracy. Infection risk ~2% per day — limit to 5–7 days, antibiotic-impregnated catheters reduce risk. Level to foramen of Monro (external auditory meatus/tragus). Set drain height (e.g., +10 cmH₂O above reference); waveform is dampened when draining — close briefly to measure accurate ICP.

Intraparenchymal Bolt

Codman, Camino, Raumedic — fiber-optic or strain-gauge placed directly in brain parenchyma. Accurate long-term, no drift issues of older fluid-coupled systems. Cannot drain CSF. Non-dominant frontal placement. Cannot re-zero in situ — calibrate at insertion only. Preferred in coagulopathic patients or when ventricles are small/slit-like.

Monroe-Kellie Doctrine

Total intracranial volume = constant: brain (~80%) + blood (~10%) + CSF (~10%). Compensatory reserve: CSF displacement to spinal canal (largest buffer) then venous blood displacement. Once reserve exhausted: exponential ICP rise from small volume additions. Why a 100 mL slow-growing meningioma may be asymptomatic while a 30 mL acute subdural causes herniation.

Cerebral Autoregulation & PRx

Normal: CBF constant at CPP 50–150 mmHg via vasomotor response. Disrupted TBI: CBF becomes pressure-passive (MAP↑ → ICP↑ → no protection). PRx (correlation MAP to ICP, 5-min rolling window): <0.2 = intact; >0.2 = impaired. PRx–CPP curve: find the CPP at minimum PRx → optimal CPP for that patient. Typically 60–80 mmHg in TBI but highly individualized.

Herniation Recognition

Cushing's triad (hypertension + bradycardia + irregular breathing) = late herniation — autoregulation lost. Arterial trace: widened PP + bradycardia (Cushing reflex). Uncal herniation: ipsilateral CN III palsy + contralateral hemiplegia. Treat immediately: hyperventilate (PaCO₂ 35, temporary), mannitol 1 g/kg IV, hypertonic saline 3% or 23.4% 30 mL bolus, emergent neurosurgical decompression.

CO₂ Reactivity & Hyperventilation

Each 1 mmHg ↓PaCO₂ = ~4% ↓CBF = ↓CBV = ↓ICP within minutes. Hyperventilation to PaCO₂ 30–35 mmHg lowers ICP rapidly. Temporary measure only — tolerance develops in 4–6h (renal bicarbonate compensation). Do not hyperventilate prophylactically (cerebral ischemia risk). Target PaCO₂ 35–40 mmHg at baseline; use 30–35 only for acute herniation as bridge to definitive intervention.

ICP Level (mmHg)	Clinical Status	Interventions
<15	Normal	Maintain CPP ≥60. HOB 30°. Normothermia. Normonatremia. Normoglycemia. Avoid ↑PEEP if possible.
15–20	Elevated — optimize basics	Analgesia/sedation, head positioning, normalize PaCO₂ (35–40), PaO₂ >60, treat fever (each 1°C ↑ = ~6% ↑CMRO₂), optimize MAP for CPP ≥60.
20–25	Treat — Tier 1	Osmotherapy: mannitol 0.25–1 g/kg IV or 3% NaCl 250 mL. CSF drainage via EVD (if in place). Re-optimize CPP target. Reassess CT for new lesion.
25–40	Aggressive — Tier 2	Continuous CSF drainage, hypertonic saline 23.4% 30 mL bolus, targeted temperature management (36°C), consider neuromuscular blockade, re-CT immediately.
>40 / A waves	Herniation imminent	Emergency hyperventilation (PaCO₂ 30–35), maximal osmotherapy, decompressive craniectomy (if surgical candidate), barbiturate coma (last resort — causes hypotension requiring vasopressors).

Part VI Pulse Wave Physics & the Vascular Tree

Pulse Wave Transformation, Reflection & Arterial Stiffness

The pressure wave generated by LV ejection does not arrive at the capillary bed unchanged. It is progressively reshaped by arterial wall mechanics and wave reflection as it travels outward, and the entire purpose of this reshaping is to convert a pulsatile, high-energy ejection into the steady, low-pressure flow that capillary exchange actually requires. The waveform you read at any given site is a record of how far the wave has traveled and how stiff the vessel bed has become.

Pressure Waveform Transformation — Proximal Aorta to Capillary

AIx

Wave Reflection & the Augmentation Index

The peripheral amplitude increase visible above is not random — it is the predictable product of wave reflection. The forward wave generated by LV ejection travels outward and partially reflects backward at points of impedance mismatch (arterial branch points, the high-resistance arteriolar bed). The forward and reflected waves summate, and where in the cardiac cycle that summation lands depends entirely on how fast the reflected wave returns — which depends on arterial stiffness.

Augmentation Index — Young Compliant Artery vs Aged Stiff Artery

Wave Reflection Formulas AIx (%) = (P2 − P1) / PP × 100 // augmentation index; P1 = forward wave shoulder, P2 = augmented peak PWV = Δd / Δt // pulse wave velocity; distance between 2 arterial sites / pulse transit time AIx@75 = AIx normalized to HR 75 bpm // HR-corrected for comparison across patients [Ref. 31] PP amplification ratio = peripheral PP / central (aortic) PP // >1.3 favorable; approaches 1.0 with vascular aging [Ref. 32]

Age Group	Brachial PP vs Aortic PP	PP Amplification	Typical AIx	Clinical Significance
Young adult (<30y)	Brachial PP up to 50% > aortic PP	High (>1.3)	Low (0–20%)	Reflected wave returns in diastole — augments coronary perfusion, protects LV. Radial SBP overestimates central SBP substantially [Ref. 32].
Middle age (40–60y)	Amplification narrowing	Intermediate	Rising (20–30%)	Aortic stiffening progresses faster than peripheral muscular arteries — central-to-peripheral stiffness gradient shrinks [Ref. 32].
Elderly (>65y)	Brachial PP ≈ aortic PP	Near 1.0 (no amplification)	High (>30%)	Reflected wave returns in systole — augments SBP directly, raises LV afterload and myocardial oxygen demand [Ref. 29, 32].

Why a Radial Arterial Line Is Not a Perfect Aortic Surrogate

This is the physiologic basis behind the radial-aortic discrepancy referenced throughout this guide (Sections 01, 07, 26). A young patient's radial SBP can legitimately exceed central aortic SBP by 10–20 mmHg due to favorable pulse pressure amplification — this is normal physiology, not measurement error. An elderly or post-CPB patient with stiff vessels shows little to no amplification, and post-bypass vasospasm can even reverse the gradient. The clinical takeaway: when radial and central pressures disagree, consider where the patient sits on the stiffness spectrum before assuming line malfunction [Ref. 33, 34].

The Arteriole — Where the Pressure Actually Drops

The SVR formula in Section 02 treats resistance as a single lumped value, but resistance is not distributed evenly across the vascular tree. Anatomically, one segment does almost all of the work.

Pressure Decrement Across the Systemic Vascular Tree

The 70% Rule

In the systemic circulation, there is minimal pressure change from the aorta through the large and small arteries — but small arteries and arterioles account for roughly 70% of the total pressure drop, and they are the principal site regulating SVR [Ref. 30]. This is anatomically distinct from the pulmonary circulation, where the drop is distributed far more evenly across arteries, capillaries, and even veins [Ref. 14] — one reason PVR and SVR behave so differently as physiologic levers.

Direct micropuncture data (hamster cheek pouch, cat mesentery) localize the steepest drop to arterioles in the 200–100 μm range, with a second, smaller drop at precapillary sphincters (15–25 μm) [Ref. 36].

Why the Smallest Vessels Aren't the Highest-Resistance Vessels

Resistance follows the Hagen-Poiseuille relationship: R ∝ 1/r⁴. A capillary has a smaller radius than an arteriole, but capillaries run in such dense parallel networks that their combined resistance is low — parallel resistors always reduce total resistance below any single resistor's value. Arterioles, with fewer parallel channels and active smooth muscle tone, are the true resistance vessels [Ref. 37]. This is also why a tiny change in arteriolar radius — from sympathetic tone, vasopressors, or local metabolic signals — produces an outsized change in SVR and regional flow.

Hemodynamic Coherence — When the Macrocirculation Lies

Every monitor discussed in this guide — arterial line, PAC, CVP, ICP — measures the macrocirculation: the pressures and flows in vessels large enough to cannulate. None of them directly see the capillary bed, where oxygen delivery actually happens. Hemodynamic coherence is the principle, formalized by Can Ince, that normalizing macrocirculatory targets (MAP, CO, ScvO₂) only restores tissue perfusion if the microcirculation remains coupled to those targets — and in shock states, that coupling is frequently lost [Ref. 38].

The Core Problem

A patient can have a normalized MAP, an adequate CO, and a reassuring ScvO₂ — every number on this guide's monitors looking acceptable — while the sublingual or splanchnic microcirculation remains shut down, capillaries unperfused, tissue hypoxic. ["Acceptable" pressure may coexist with poor microcirculation — the same observation made independently in bedside critical care teaching, and the entire rationale for handheld vital microscopy and lactate-trend monitoring in resuscitated shock [Ref. 38, 39].]

Mechanism (Ince, 2015)	Pathophysiology	Clinical Correlate
Type 1 — Heterogeneous perfusion	Obstructed capillaries sit immediately adjacent to well-perfused ones, producing patchy tissue oxygenation despite normal bulk flow	Classic septic microcirculatory pattern; visualized directly on sublingual videomicroscopy [Ref. 38]
Type 2 — Hemodilution	Aggressive crystalloid resuscitation dilutes RBC-filled capillaries, increasing the diffusion distance between red cells and tissue cells	Argues against unlimited fluid administration once macrocirculatory targets are met; supports restrictive fluid strategies in later sepsis phases
Type 3 — Stasis	Increased arteriolar resistance or venous pressure halts microcirculatory RBC flow even when systemic pressure is preserved	Relevant to high-dose vasopressor states and elevated CVP — supports avoiding venous congestion (echoes the CVP/organ perfusion caution in Section 17)
Type 4 — Capillary leak / edema	Glycocalyx injury and capillary leak increase diffusive distance independent of flow	Explains why some edematous, "well-resuscitated" patients remain cryptically hypoperfused

When Coherence Holds vs Breaks

In early, uncomplicated shock, macro- and microcirculatory changes track together — fluid that raises CO also raises microvascular flow. Once inflammation and endothelial/glycocalyx injury set in, this coupling degrades: a fluid challenge can increase CI, MAP, and CVP in lockstep while sublingual and gut microcirculatory flow indices fail to follow [Ref. 40]. Time matters — Boerma et al. demonstrated that the relationship between intestinal and sublingual microcirculation itself shifts over the first three days of septic shock [Ref. 41].

Practical Implication for This Guide's Monitors

None of this argues against the PAC, arterial line, or CVP — it argues for humility about what they prove. A normalized hemodynamic profile (Sections 15–16, 23) is necessary but not sufficient evidence of adequate resuscitation. Lactate clearance, capillary refill, and skin mottling remain useful precisely because they are downstream of the microcirculation in a way that MAP and CO are not. Where available, point-of-care sublingual videomicroscopy directly visualizes the compartment none of the catheters in this guide can reach.

The Counterargument — Coherence Is Debated, Not Settled

Hernandez and Teboul published a direct challenge to the framework as commonly applied, arguing that apparent "dissociation" in some studies reflects assessment timing rather than a true loss of coupling, and that early normalization of macrocirculatory parameters and lactate still correlates with improved survival in large cohorts [Ref. 42]. Ince's response defended the concept while acknowledging the methodological critique [Ref. 42]. Treat hemodynamic coherence as an important conceptual corrective to monitor-worship, not as a fully validated bedside test with its own actionable thresholds.

References & Further Reading

Primary References

[1] Scheeren TWL, Saugel B. Management of Intraoperative Hypotension: Prediction, Prevention and Personalization. In: Vincent JL (ed). Annual Update in Intensive Care and Emergency Medicine 2018. Springer, Cham. DOI: 10.1007/978-3-319-73670-9.

[2] Hernandez G, Messina A, Kattan E. Invasive arterial pressure monitoring: much more than mean arterial pressure! Intensive Care Medicine 48:1495–1497 (2022). DOI: 10.1007/s00134-022-06854-3.

Fluid Responsiveness & Dynamic Indices

[3] Cannesson M, Le Manach Y, Hofer CK, et al. Assessing the diagnostic accuracy of pulse pressure variations for the prediction of fluid responsiveness: a "gray zone" approach. Anesthesiology 115(2):231–241 (2011). PMID: 21705869.

[4] Biais M, Ehrmann S, Mari A, et al. Clinical relevance of pulse pressure variations for predicting fluid responsiveness in mechanically ventilated ICU patients: the grey zone approach. Crit Care 18:587 (2014). DOI: 10.1186/s13054-014-0587-9.

[5] Monnet X, Marik P, Teboul JL. Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis. Intensive Care Med 42(12):1935–1947 (2016). PMID: 26825952.

[6] Monnet X, Teboul JL. Passive leg raising: five rules, not a drop of fluid! Crit Care 19:18 (2015). DOI: 10.1186/s13054-014-0708-5.

[7] Marik PE, Cavallazzi R, Vasu T, Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med 37(9):2642–2647 (2009). PMID: 19602972.

Hypotension Prediction & Intraoperative Management

[8] Hatib F, Jian Z, Buddi S, et al. Machine-learning algorithm to predict hypotension based on high-fidelity arterial pressure waveform analysis. Anesthesiology 129(4):663–674 (2018). [HPI derivation study].

[9] Davies SJ, Vistisen ST, Jian Z, et al. Ability of an arterial waveform analysis–derived Hypotension Prediction Index to predict future hypotensive events in surgical patients. Anesth Analg 130(2):352–359 (2020). DOI: 10.1213/ANE.0000000000004121.

[10] Michard F, Chemla D, Teboul JL. Applicability of pulse pressure variation: how many shades of grey? Crit Care 19:144 (2015). DOI: 10.1186/s13054-015-0869-x.

Right Heart Catheterization & PAC

[11] Kern MJ, et al. Practical guidance for hemodynamic assessment by right heart catheterization in management of heart failure. JACC Heart Fail 12(9):1497–1516 (2024).

[12] Garan AR, et al. Complete hemodynamic profiling with pulmonary artery catheters in cardiogenic shock is associated with lower in-hospital mortality. JACC Heart Fail 8(11):903–913 (2020). DOI: 10.1016/j.jchf.2020.08.010.

[13] Hahn RT, et al. The accuracy of a large V wave in the pulmonary capillary wedge pressure waveform for diagnosing current mitral regurgitation. Cardiology 141(1):46–55 (2018). [Giant V wave specificity/sensitivity data].

[14] West JB. Pulmonary blood flow and metabolism. In: Respiratory Physiology: The Essentials, 9th ed. Lippincott Williams & Wilkins, 2012. [West Zones].

[15] Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med 41(7):1774–1781 (2013). PMID: 23774337. [CVP AUC 0.56].

Advanced Hemodynamic Parameters

[16] Hochman JS, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. JACC 44(2):340–348 (2004). DOI: 10.1016/j.jacc.2004.03.060. [CPO <0.6 W threshold].

[17] Lim HS, et al. Pulmonary artery pulsatility index: physiological basis and clinical application. Eur J Heart Fail 22(1):32–38 (2020). PMID: 31680410. [PAPI <0.9 RV failure threshold].

IABP & MCS

[18] Thiele H, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12-month results of a randomised, open-label trial. Lancet 382(9905):1638–1645 (2013).

[19] Sayer GT, Semigran MJ. Mechanical Circulatory Support: State of the Art and New Horizons. JACC Heart Fail (2023). [LVAD, Impella, VA-ECMO waveform characteristics].

ICP Monitoring & Neuromonitoring

[20] Carney N, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery 80(1):6–15 (2017). [BTF guidelines; CPP targets; ICP treatment thresholds].

[21] Chesnut RM, et al. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med 367:2471–2481 (2012). [BEST:TRIP trial].

[22] Czosnyka M, Pickard JD. Monitoring and interpretation of intracranial pressure. J Neurol Neurosurg Psychiatry 75(6):813–821 (2004). [PRx, autoregulation, optimal CPP].

[23] Lundberg N. Continuous recording and control of ventricular fluid pressure in neurosurgical practice. Acta Psychiatr Scand Suppl 36(149):1–193 (1960). [Original Lundberg A/B/C wave description].

Specialty Populations

[24] Clark SL, Cotton DB, Lee W, et al. Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol 161(6):1439–1442 (1989). [Reference values for pregnant hemodynamics].

[25] Evans L, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Intensive Care Med 47:1181–1247 (2021).

[26] Kliegman RM et al. Nelson Textbook of Pediatrics, 21st ed. Elsevier, 2020. [Pediatric normal hemodynamic values and transitional circulation].

[27] Konstantinides SV, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism. Eur Heart J 41(4):543–603 (2020). [PE hemodynamic classification, intervention thresholds].

Pulse Wave Physics, Arterial Stiffness & Wave Reflection

[28] Mitchell GF, Parise H, Benjamin EJ, et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 43(6):1239–1245 (2004). DOI: 10.1161/01.HYP.0000128420.01881.aa.

[29] O'Rourke MF. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension 15(4):339–347 (1990). PMID: 2180816.

[30] Nichols WW, O'Rourke MF, Vlachopoulos C. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles, 6th ed. Hodder Arnold, London, 2011. [Standard reference text for PWV, augmentation index, and the systemic pressure-drop distribution.]

[31] Chung JW, Lee YS, Kim JH, et al. Reference values for the augmentation index and pulse pressure in apparently healthy Korean subjects. Korean Circ J 40(4):165–171 (2010). [AIx@75 heart-rate normalization methodology.]

[32] Avolio AP, Van Bortel LM, Boutouyrie P, et al. Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension 54(2):375–383 (2009). DOI: 10.1161/HYPERTENSIONAHA.109.134379.

[33] Pauca AL, Wallenhaupt SL, Kon ND, Tucker WY. Does radial artery pressure accurately reflect aortic pressure? Chest 102(4):1193–1198 (1992). PMID: 1395767.

[34] Kelly R, Hayward C, Avolio A, O'Rourke M. Noninvasive determination of age-related changes in the human arterial pulse. Circulation 80(6):1652–1659 (1989). DOI: 10.1161/01.cir.80.6.1652.

Vascular Resistance Distribution

[35] (Pulmonary resistance distribution — see Ref. 14, West.)

[36] Davis MJ, Ferrer PN, Gore RW. Vascular anatomy and hydrostatic pressure profile in the hamster cheek pouch. Am J Physiol 250(2 Pt 2):H291–H303 (1986). [Primary micropuncture data localizing the principal site of arteriolar resistance.]

[37] Alahdab F, Raja A. Physiology, Peripheral Vascular Resistance. StatPearls [Internet]. NCBI Bookshelf, updated 2023. [Hagen-Poiseuille relationship and arteriolar resistance regulation.]

Hemodynamic Coherence & Microcirculation

[38] Ince C. Hemodynamic coherence and the rationale for monitoring the microcirculation. Crit Care 19(Suppl 3):S8 (2015). DOI: 10.1186/cc14726. [Primary source; defines hemodynamic coherence and the four mechanisms of microcirculatory dissociation.]

[39] Lima A, Jansen TC, van Bommel J, Ince C, Bakker J. The prognostic value of the subjective assessment of peripheral perfusion in critically ill patients. Crit Care Med 37(3):934–938 (2009). PMID: 19237902.

[40] Edul VSK, Ince C, Navarro N, et al. Dissociation between sublingual and gut microcirculation in the response to a fluid challenge in postoperative patients with abdominal sepsis. Ann Intensive Care 4:39 (2014). DOI: 10.1186/s13613-014-0039-3.

[41] Boerma EC, van der Voort PHJ, Spronk PE, Ince C. Relationship between sublingual and intestinal microcirculatory perfusion in patients with abdominal sepsis. Crit Care Med 35(4):1055–1060 (2007). PMID: 17334248.

[42] Hernández G, Teboul JL. Is the macrocirculation really dissociated from the microcirculation in septic shock? Intensive Care Med 42(10):1621–1624 (2016). DOI: 10.1007/s00134-016-4416-2. [Critical counterpoint to the coherence framework; see also Ince's reply in the same volume.]

Compiled for clinical reference. Not a substitute for institutional protocols, real-time clinical judgment, or senior consultation. Hemodynamic targets are population-level starting points — individualize to patient physiology and trending data. Document version updated June 2026.